About Us
Founded by Chinese American Hematologists and Oncologists in 2005, CAHON is dedicated to fostering communications among Chinese American medical professionals for the delivery of high-quality health care to patients with neoplastic and hematological diseases, and to promoting the exchange of medical information between the United States and China in the fields of hematology and oncology. CAHON strives to serve as a bridge of medical and educational exchange for its members and between Chinese and American Hematology-Oncology.
Upcoming Events
Summer Symposium & Reception
May 30, 2026
Metropolitan in Willis Tower
233 South Wacker Drive, 66th Floor
Chicago, IL, 60606
CAHON 20th Anniversary
Membership
Become a
Member
The Value of a CAHON Membership
Connect with a community of Chinese American hematologists and oncologists dedicated to advancing patient care, groundbreaking research, and professional excellence through global collaboration.
By joining CAHON you will have access to:
- Career development resources
- A private WeChat group where you can connect with colleagues to pose clinical questions
- Exclusive access to conferences and symposiums with reduced or waived registration fees and priority hotel reservations
- Travel grant opportunities
- And much more...
Featured News
- 2026 CAHON Community Oncology Forum Meeting Report
- CAHON Connect December Newsletter
- CAHON Mourns the Loss of Dr. Edward Chu
- CAHON 2025 New York Oncology Forum Meeting Report
- CAHON Connect September Newsletter
- 2025 Lifetime Achievement and Outstanding Service Award Recipients
- Please Welcome Our New CAHON Board Member!
- Thank You to Our Outgoing Board Member!
- CAHON Connect April Newsletter
- CAHON Bylaws Revision - Membership Eligibility
"Journal of Hematology & Oncology provides a forum for top-quality research and is the leading title in hematology and oncology, with an Impact Factor ranked in Q1 in both categories. The journal also publishes reviews and research highlights from leading experts in the field. Research is shared with fast turnaround times in an open access format among laboratory scientists, physician scientists, hematologists and oncologists."
Prof Delong Liu, Editor-in-Chief
Journal of Hematology & Oncology